EISAI-E2007-G000-235

Study Sponsor: Eisai

Study Title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to Less Than 18 Years of Age) With Inadequately Controlled Partial-onset Seizures

Medicine or Vaccine (generic name)

perampanel

Sponsor Identification Number

E2007-G000-235

Trial Registry Identification Number(#'s)

NCT01161524
EU CTR 2010-018518-56

Medical Condition

Epilepsy

Phase

Phase 2

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01161524

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-018518-56

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

November 2018